Alcohol, Tobacco, and Other Drugs

NOTE: Sessions listed in italics have been organized by another section, SPIG, or caucus but are cosponsored by Alcohol, Tobacco, and Other Drugs.

Monday, November 13, 2000

12:30 PM-2:00 PM Mon
3002.0Human Papilloma Virus: Public Health, Sociopolitical and Therapeutic Controversies ()
3003.0Monitoring and Countering Tobacco Industry Influence ()
3004.0Improving Prevention and Treatment ()
3039.0Substance Use among Lesbian, Gay, Bisexual, and Transgender Populations ()
2:30 PM-4:00 PM Mon
3077.0Tobacco Control in Arizona: A Roundtable ()
3078.0David vs. Goliath: Public Health Efforts to Counter the Alcohol Industry ()
3079.0Costs of Alcohol and Drug Abuse ()
4:30 PM-6:00 PM Mon
3160.0Women and Their Nicotine Affairs ()
3161.0School-Based Substance Use Prevention: The State of the Nation ()
3162.0ATOD Late-Breaker Session I ()
3163.0Syringe Access, Use & Discard: Context in AIDS Risk ()
3164.0Patterns of Alcohol Consumption and Implications for Policy ()
3165.0New Methods for Alcohol Problem Assessment and Intervention ()
3166.0Emerging Patterns in Alcohol-Related Problems ()
3181.0Alcohol, Drugs, and Disability: Breaking the Silence ()
8:30 PM-10:00 PM Mon
3237.0Women, Alcohol, And Violence ()
3239.0Bridging the Gap between Research and Clinical Practice: The Evaluation of Early Start, an Obstetric Clinic-Based, Perinatal Substance Abuse Treatment Program ()
3240.0Prevalence and Risk Behaviors for HIV among Youth and Adults ()
3241.0Monitoring the Tobacco Epidemic: Data Sources ()
3247.0HIV and Injecting Drug Users (IDUs) ()

Tuesday, November 14, 2000

8:30 AM-10:00 AM Tue
4002.1ATOD Late-Breaker Session II ()
4003.0Impact of Physician Monitoring on Utilization and Appropriateness of Benzodiazepine Prescribing on a Medicaid Population ()
4004.0Research Update on Hepatitis C among Drug Abusers: What Are the Health Consequences and Implications for Treatment, Prevention, and the Community? ()
4005.0International Tobacco Control Poster Session ()
4006.0Smoking Cessation Poster Session I ()
4007.0Smoking Cessation Poster Session II ()
4008.0Environmental Tobacco Smoke Poster Session ()
4009.0Psychosocial and Behavioral Factors in Tobacco Poster Session ()
4010.0State and Local Tobacco Control Programs and Evaluation Poster Session ()
4011.0Special Populations and Tobacco Poster Session ()
4012.0Tobacco Access and Media Poster Session ()
12:30 PM-2:00 PM Tue
4092.0Reducing Alcohol-Related Harm: Establishing and Enforcing Alcohol Policies ()
4093.0Looking Backward and Moving Forward in Tobacco Control Research Methodology ()
4094.0Special ATOD Issues in Public Health ()
4095.0Making Treatment Work ()
4096.0Factors Influencing Services Utilization by Pregnant and Parenting Adolescents ()
4097.0Children at Risk Poster Session ()
4098.0Monitoring HIV and Injection Drug Users Issues II ()
4099.0Monitoring HIV, HPC, and Injection Drug Users Issues I ()
4100.0Better Methods for Research on Treatment and Prevention ()
4101.0Alcohol and Youth: Drinking-Related Behaviors and Risks ()
4101.1The Changing Patterns of Drug Use ()
4101.2Impacts on Tobacco Use and Policy ()
4101.3Drug Abuse Prevention Poster Session ()
4101.4Factors Affecting Drug Use Poster Session ()
4101.5National Tobacco Usage Poster Session ()
2:30 PM-4:00 PM Tue
4163.0International Issues in Tobacco Control ()
4164.0The Collaborative Injection Drug User Study (CIDUS 2): Parenterally and Sexually Transmitted Infection among Young Injection Drug Users ()
4165.0Early Intervention: Prenatal and Perinatal Care ()
4166.0Research on Drinking Patterns in Special Populations ()
4:30 PM-6:00 PM Tue
4236.0Evaluating ATOD Internet Services ()
4237.0Hot Topics in Tobacco: A Latebreaker Session ()
4238.0Methadone Maintenance Therapy: Policy and Practice ()
8:30 PM-10:00 PM Tue
4305.0Patterns and Progress in Syringe Exchange ()
4306.0Youth Tobacco Issues: A Roundtable Discussion ()
4307.0Prevention Interventions and Consequences in the in the Workplace ()
4313.0HIV and Needle Exchange Programs ()

Wednesday, November 15, 2000

8:30 AM-10:00 AM Wed
5002.0Smoking Cessation ()
5003.0Alcohol Issues in Culturally Diverse Populations ()
5004.0Emerging Tobacco Advertising and Marketing Issues ()
5005.0The Substance Abuse Treatment Study (SATS): A Developmental Analysis of Content, Process and Context ()
5005.1Factors Impacting Substance Abuse Treatment ()
12:30 PM-2:00 PM Wed
5089.0Managed Care and Treatment Entry ()
5090.0Findings from the 1996 Robert Wood Johnson Foundation Study of Smoking and Tobacco Use Among Young People ()
5091.0Youth and Alcohol: Risks and Protective Factors ()
2:30 PM-4:00 PM Wed
5167.0Commitment to Wellness: Recovering from Addictive Diseases and Mental Disorders ()
5168.0Case Studies in Tobacco Control Policy Development: Lessons Learned and More to Do ()
5169.0College and Alcohol ()
5170.0Impact of Managed Care on Treatment Outcomes ()
4:30 PM-6:00 PM Wed
5224.0Innovative Monitoring Approaches of Tobacco Control ()
5225.0Strategies for Treatment and Prevention of Alcohol Problems among Women ()
5226.0Substance Abuse Treatment Duration and Completion: What Matters? ()
8:30 PM-10:00 PM Wed
5298.0Increasing Service to Indigent Substance Abusers ()
5299.0Treating Tobacco Use and Dependence: Presenting the Findings from the Updated AHCPR Clinical Practice Guideline for Smoking Cessation ()
5300.0New Treatments for Alcoholism: Research Implications ()
5301.0Scarce Dollars: Cost-Effectiveness and Substance Abuse Treatment ()

Thursday, November 16, 2000

8:30 AM-10:00 AM Thu
6000.0National and State Tobacco Policy and Program Evaluation ()
6001.0Reducing Underage Drinking: Alcohol Policy Strategies ()
6002.0MJ: Gateway or Pharmaceutical? ()

Browse the complete program of The 128th Annual Meeting of APHA